kotak-logo
Chandan Healthcare Share Price

Chandan Healthcare Share Price

263
+9.00 (3.54%)
CHANDAN • 11 Mar, 2026 | 12:20 PM

Chandan Healthcare Stock Performance

1W Return1.62
1Y Return52.91
Today's Low261.2
Prev. Close254.00
Mkt Cap (Cr.)621.08
1M Return-11.31
3Y Return0.00
52-Week High358
Open279.95
PE Ratio24.90
6M Return17.88
Today's High280
52-Week Low150.3
Face Value10

Chandan Healthcare Company background

Founded in: 2003
Managing director: AMAR SINGH
Chandan Healthcare Limited, established on September 03, 2003, specializes in operating stateoftheart laboratories that offer comprehensive pathological investigations. The Company run a diagnostic network in North India with pathology and radiology testing services. Their services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, Xrays, and MRIs. The Company commenced business by starting its first diagnostic centre in Indra Nagar, Lucknow in 2003. Later, it started the diagnostic centre in Dehradun in 2013. It has established a chain of Retail Pharmacies in Uttar Pradesh, Uttarakhand, and Delhi, along with wholesale distribution to our retail outlets and hospitals. Operating in Lucknow, Chandan Hospital Limited is a 300bed tertiary care MultiSuperspecialty Hospital that has quickly gained recognition as one of the leading hospitals in the region since its opening on October 1st, 2018.As of August 31, 2024, the Company has 1 flagship laboratory, 7 central laboratories, 26 satellite centres, more than 300 collection centres and located across India, with facilities in more than 15 cities and towns across Uttar Pradesh and more than 10 cities and towns in Uttarakhand. Out of various laboratories, 8 are National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited while three of the diagnostic centres have National Accreditation Board for Hospitals Healthcare Providers (NABH) accreditation.Apart from these, the Company provide nearly 1,496 tests across different specialties. These test menu includes 481 routine pathology tests, covering basic biochemistry and hematology, as well as 1,015 specialized pathology tests, such as immohistopathology, and molecular pathology, and 545 radiology tests, including basic xrays, ultrasonography (USG), computed tomography (CT), magnetic resonance imaging (MRI), and specialized CT scans. Radiology facilities have 11 CT scanners and 4 MRI machines. Committed to accuracy and reliability, the Company supports healthcare professionals and patients by delivering essential diagnostic services. The Company launched the IPO aggregating an issuance of 67,52,000 equity shares of face value of Rs 10 each by raising Rs 106.98 Cr, comprising a fresh issue of 44,52,064 equity shares aggregating to Rs 70.41 Cr and the offer for sale of 22,96,936 equity shares aggregating to Rs 36.57 Cr in February, 2025.

Chandan Healthcare Financial Highlights


For the full year FY2025–2026, revenue reached ₹232.17 crore and profit touched at ₹23.52 crore.

Chandan Healthcare Share Price Today


As of 11 Mar 2026, Chandan Healthcare share price is ₹263. The stock opened at ₹280 and had closed at ₹254 the previous day. During today’s trading session, Chandan Healthcare share price moved between ₹261.20 and ₹280.00, with an average price for the day of ₹270.60. Over the last 52 weeks, the stock has recorded a low of ₹150.30 and a high of ₹358.00. In terms of performance, Chandan Healthcare share price has increased by 15.6% over the past six months and has increased by 48.40% over the last year.
Read More
View details of Market Depth

Chandan Healthcare Fundamental

Market Cap (in crs)

621.08

Face Value

10

Turnover (in lacs)

263.00

Key Metrics

Qtr Change %
26.54% Fall from 52W High
-12.1
Dividend yield 1yr %
0

Chandan Healthcare Key Financials

View more
Loading chart...
Chandan Healthcare Quarterly Revenue
Chandan Healthcare Yearly Revenue
Chandan Healthcare Quarterly Net Profit/Loss
Chandan Healthcare Yearly Net Profit/Loss

Chandan Healthcare Result Highlights

  • Chandan Healthcare Ltd reported a - quarter-on-quarter (QoQ) - in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.3%.

  • Its expenses for the quarter were - by - QoQ and up 17.1% YoY.

  • The net profit - - QoQ and increased 3.5% YoY.

  • The earnings per share (EPS) of Chandan Healthcare Ltd stood at 1.86 during Q3 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Chandan Healthcare Technical Analysis

Moving Averages Analysis
263
Current Price
Bullish Moving Averages
7
Bearish Moving Averages
9
Day EMA5
256.70
Day EMA10
260.50
Day EMA12
261.70
Day EMA20
265.80
Day EMA26
268.30
Day EMA50
276.00
Day EMA100
277.60
Day EMA200
252.60
Delivery & Volume
Loading chart...

Day

65.50%

Week

81.70%

Month

73.50%

Delivery & Volume

254.40
Pivot
Resistance
First Resistance
257.80
Second Resistance
261.60
Third Resistance
265
Support
First Support
250.60
Second support
247.20
Third Support
243.40
Relative Strength Index
40.11
Money Flow Index
21.24
MACD
-6.54
MACD Signal
-5.34
Average True Range
11.09
Average Directional Index
23.55
Rate of Change (21)
-6.57
Rate of Change (125)
9.01
Compare

Chandan Healthcare Shareholding Pattern

Promoter
49.5%
Domestic Institutions
4.8%
Public
45.8%

Chandan Healthcare Latest News

13 OCT 2025 | Monday
17 FEB 2025 | Monday
10 FEB 2025 | Monday

Please be aware that Chandan Healthcare stock prices are subject to continuous fluctuations due to various factors.